Table 3.
Population | NT-ProBNP (pg/ml) | All-cause mortality | ||
---|---|---|---|---|
HR | 95% CI | p-value | ||
Whole population | Per 1 SD | 1.11 | 1.07–1.17 | < 0.001 |
< 100 | 1.00 | Ref. | ||
100–299 | 1.61 | 1.12–2.32 | 0.012 | |
≥ 300 | 2.96 | 1.75–5.00 | < 0.001 | |
HbA1c < 5.7% | Per 1 SD | 1.12 | 1.07–1.18 | < 0.001 |
< 100 | 1.00 | Ref. | ||
100–299 | 1.72 | 1.00–2.95 | 0.050 | |
≥ 300 | 3.12 | 1.50–6.49 | 0.003 | |
HbA1c 5.7–6.4% | Per 1 SD | 1.23 | 1.05–1.43 | 0.010 |
< 100 | 1.00 | Ref. | ||
100–299 | 1.84 | 0.92–3.67 | 0.082 | |
≥ 300 | 3.79 | 1.59–9.01 | 0.003 | |
Diabetes | Per 1 SD | 1.10 | 1.05–1.16 | < 0.001 |
< 100 | 1.00 | Ref. | ||
100–299 | 1.44 | 0.81–2.56 | 0.206 | |
≥ 300 | 2.43 | 0.98–6.06 | 0.056 |
Covariates included in model were age, sex, race-ethnicity, body mass index, education, cigarette smoke, total cholesterol, eGFR, blood pressure category, prevalent cardiovascular disease and alcohol consumption
CI confidence interval, NT-ProBNP N-terminal pro-B natriuretic peptide